KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Debt Ratio (2017 - 2025)

Amneal Pharmaceuticals (AMRX) has 8 years of Debt Ratio data on record, last reported at 0.65 in Q4 2024.

  • For Q4 2024, Debt Ratio fell 7.31% year-over-year to 0.65; the TTM value through Dec 2024 reached 0.65, down 7.31%, while the annual FY2024 figure was 0.65, 7.31% down from the prior year.
  • Debt Ratio reached 0.65 in Q4 2024 per AMRX's latest filing, down from 0.69 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.7 in Q2 2023 and bottomed at 0.01 in Q1 2020.
  • Average Debt Ratio over 5 years is 0.58, with a median of 0.69 recorded in 2022.
  • Peak YoY movement for Debt Ratio: tumbled 98.25% in 2020, then surged 6456.59% in 2021.
  • A 5-year view of Debt Ratio shows it stood at 0.69 in 2020, then dropped by 0.2% to 0.69 in 2021, then dropped by 0.33% to 0.69 in 2022, then increased by 0.99% to 0.7 in 2023, then fell by 7.31% to 0.65 in 2024.
  • Per Business Quant database, its latest 3 readings for Debt Ratio were 0.65 in Q4 2024, 0.69 in Q3 2024, and 0.68 in Q2 2024.